New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone by Soyka M

Get full text

Should we Test the Prothrombin Time in Anticoagulated Epistaxis Patients? by Michael B. Soyka M.D., David Holzmann M.D.

Get full text

The C(-1019)G 5-HT1A promoter polymorphism and personality traits: no evidence for significant association in alcoholic patients by Zill P, Preuss UW, Bondy B, Koller G, Soyka M

Get full text

Risk profiles of treatment noncompletion for inpatients and outpatients undergoing alcohol disorder rehabilitation treatment by Preuss UW, Zimmermann J, Schultz G, Watzke A, Schmidt P, Loehnert B, Soyka M

Get full text

Genome-wide association study for alcohol-related cirrhosis identifies risk loci in MARC1 and HNRNPUL1 by Innes, H, Buch, S, Hutchinson, S, Guha, IN, Morling, JR, Barnes, E, Irving, W, Forrest, E, Pedergnan, V, Goldberg, D, Aspinall, E, Barclay, S, Hayes, P, Dillon, J, Nischalke, HD, Lutz, P, Spengler, U, Fischer, J, Berg, T, Brosch, M, Eyer, F, Datz, C, Mueller, S, Peccerella, T, Deltenre, P, Marot, A, Soyka, M, McQuillin, A, Morgan, MY, Hampe, J, Stickel, F